CRDL
Cardiol Therapeutics Inc.NASDAQHealthcare$1.41-1.42%ClosedMarket Cap: $157.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
17.19
P/S
0.00
EV/EBITDA
-5.71
DCF Value
$0.24
FCF Yield
-11.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-218.5%
ROA
-268.7%
ROIC
-374.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | NaN% | $-10.2M | $-10.0M | $-0.12 | — |
| Q2 2025 | $0.00 | NaN% | $-7.7M | $-8.4M | $-0.10 | — |
| Q1 2025 | $0.00 | NaN% | $-8.4M | $-8.3M | $-0.10 | — |
| Q4 2024 | $0.00 | -Infinity% | $-6.9M | $-5.7M | $-0.12 | — |
| FY 2024 | $0.00 | NaN% | $-40.3M | $-36.7M | $-0.51 | — |
| Q3 2024 | $0.00 | NaN% | $-14.1M | $-12.7M | $-0.18 | — |
| Q2 2024 | $0.00 | -Infinity% | $-5.7M | $-4.8M | $-0.10 | — |
| Q1 2024 | $0.00 | -Infinity% | $-8.4M | $-9.2M | $-0.14 | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.1M | $-5.8M | $-0.12 | — |
| FY 2023 | $0.00 | -Infinity% | $-22.5M | $-21.2M | $-0.44 | — |
| Q3 2023 | $0.00 | -Infinity% | $-5.6M | $-4.4M | $-0.09 | — |
| Q2 2023 | $0.00 | -Infinity% | $-4.8M | $-5.6M | $-0.12 | — |